Overactive bladder syndrome (OAB) has made increasing progress in mechanism and treatment research. Traditional Chinese medicine (TCM) is a common complementary therapy for OAB, and it has been found to be effective. However, the intervention mechanism of TCM in the treatment of OAB is still unclear. The aim of this review is to consolidate the current knowledge about the mechanism of TCM: acupuncture, moxibustion, herbs in treating OAB, and the animal models of OAB commonly used in TCM. Finally, we put forward the dilemma of TCM treatment of OAB and discussed the insufficiency and future direction of TCM treatment of OAB.
Background The ESC Guidelines recommend the measurement of N-terminal pro B-type natriuretic peptide (NT-proBNP) concentration in all patients who present to emergency rooms with acute dyspnoea and suspected acute decompensated heart failure (HF), with a decision cut-off (NT-proBNP<300pg/mL) for the exclusion of acute decompensated HF (ADHF). HeartLogic is a multisensor algorithm that has been developed and validated to proactively provide alerts for worsening heart failure. Purpose The purpose of this analysis was to compare the diagnostic accuracy of NT-proBNP and HeartLogic to rule out ADHF in acute settings. Methods The MultiSENSE study followed 900 HF patients with implanted CRT-Ds for up to 1 year. All hospitalizations were adjudicated by an independent panel of clinicians, and classified as HF or non-HF based on the presenting cause. Optional NT-proBNP tests were conducted when patients were hospitalized. The composite HeartLogic index of the day before each of the hospitalization dates were extracted to differentiate HF and non-HF hospitalizations. By varying the HeartLogic index decision cutoff, a ROC curve was generated to assess the prediction accuracy of HeartLogic and compared to the counterpart performance of NT-proBNP using Hanley and McNeil's method. Results Of the total 603 hospitalizations, 76 hospitalizations (52 HF, 24 non-HF) had both valid NT-proBNP measures within 48 hours of admission (71 within 24 hours), and valid HeartLogic for the day before the hospitalization date. Figure 1 illustrates that the HeartLogic -based ROC was similar to the ROC of NT-proBNP (AUC of 0.809 and 0.803, respectively, p=0.932). An exclusion criterion of HeartLogic index <1 achieved the same performance as an NT-proBNP<300pg/ml (sensitivity 0.962, NPV 0.778), and the agreement between the two criteria was 84.2%. Limiting the evaluation to 52 hospitalizations with acute dyspnea (42 HF, 10 non-HF), the performance of HeartLogic and NT-proBNP were similar (p=0.906). Expanding the evaluation of HeartLogic across all 467 hospitalizations with HeartLogic data (89 HF, 378 non-HF), performance was still similar (sensitivity 0.934, NPV 0.876 for the criterion of HeartLogic index <1; AUC of 0.734, p=0.166). Conclusion HeartLogic showed similar accuracy for differentiating HF and non-HF hospitalizations in the MultiSENSE dataset as NT-proBNP. HeartLogic may be used in the acute setting to exclude acute decompensated heart failure.